Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics
Pathology - Research and Practice · 2024
DOI: 10.1016/j.prp.2024.155346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Shivkanya Fuloria und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, AIMST University, Kedah 08100, Malaysia. Hauptthemen laut MEDLINE: Osteosarcoma, Wnt Signaling Pathway, Bone Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 121 Literaturangaben.
Abstract (Originalsprache)
Osteosarcoma (OS) is a bone cancer which stems from several sources and presents with diverse clinical features, making evaluation and treatment difficult. Chemotherapy tolerance and restricted treatment regimens hinder progress in survival rates, requiring new and creative therapeutic strategies. The Wnt/β-catenin system has been recognised as an essential driver of OS development, providing potential avenues for therapy. Non-coding RNAs (ncRNAs), such as circular RNAs (circRNAs), long non-coding RNAs (lncRNAs), and microRNAs (miRNAs), are essential in modulating the Wnt/β-catenin cascade in OS. MiRNAs control the system by targeting vital elements, while lncRNAs and circRNAs interact with system genes, impacting OS growth and advancement. This paper thoroughly analyses the intricate interplay between ncRNAs and the Wnt/β-catenin cascade in OS. We examine how uncontrolled levels of miRNAs, lncRNAs, and circRNAs lead to an abnormal Wnt/β-catenin network, which elevates the development, spread, and susceptibility to the treatment of OS. We emphasise the potential of ncRNAs as diagnostic indicators and avenues for treatment in OS care. The review offers valuable insights for academics and clinicians studying OS aetiology and creating new treatment techniques for the ncRNA-Wnt/β-catenin cascade. Utilising the oversight roles of ncRNAs in the Wnt/β-catenin system shows potential for enhancing the outcomes of patients and progressing precision medicine in OS therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, AIMST University, Kedah 08100, Malaysia.
- Chandigarh Pharmacy College, Chandigarh Group of Colleges, Jhanjheri, Mohali, Punjab 140307, India.
- Department of Chemistry and Biochemistry, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India.
- Centre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, India; Department of Pharmacology, Kyrgyz State Medical College, Bishkek, Kyrgyzsta…
- Graphic Era (Deemed to be University), Clement Town, Dehradun 248002, India; Graphic Era Hill University, Clement Town, Dehradun 248002, India.
- Department of Sciences, Vivekananda Global University, Jaipur, Rajasthan 303012, India.
Zitieren
APA
Fuloria, S., Yadav, G., Menon, S. V., Ali, H., Pant, K., Kaur, M., Deorari, M., Sekar, M., Narain, K., Kumar, S., & Fuloria, N. K. (2024). Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155346
Vancouver
Fuloria S, Yadav G, Menon SV, Ali H, Pant K, Kaur M, et al. Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155346
BibTeX
@article{Fuloria2024,
author = {Fuloria, Shivkanya and Yadav, Geeta and Menon, Soumya V and Ali, Haider and Pant, Kumud and Kaur, Mandeep and Deorari, Mahamedha and Sekar, Mahendran and Narain, Kamal and Kumar, Sokindra and Fuloria, Neeraj Kumar},
title = {Targeting the Wnt/β-catenin cascade in osteosarcoma: The potential of ncRNAs as biomarkers and therapeutics},
journal = {Pathology - Research and Practice},
year = {2024},
doi = {10.1016/j.prp.2024.155346}
}
EUVIMED